PRHSX primarily invests in health care and life sciences companies, with a focus on growth through high-quality firms in pharmaceuticals, health care services, medical devices, and biotechnology. It leans towards large- and mid-cap stocks and may mix growth investing with a value approach during high valuation periods. The fund also has scope for foreign stock investments and may hold positions in private and newly public companies, adapting to market and sector dynamics.